Cargando…
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
BACKGROUND: Systemic therapies, including immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs), have challenged the use of conventional therapies for hepatocellular carcinoma (HCC). It is crucial to determine which patients could benefit most from combination therapy. This study...
Autores principales: | Zhao, Man, Duan, Xiaoling, Han, Xin, Wang, Jinfeng, Han, Guangjie, Mi, Lili, Shi, Jianfei, Li, Ning, Yin, Xiaolei, Hou, Jiaojiao, Yin, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024177/ https://www.ncbi.nlm.nih.gov/pubmed/35463384 http://dx.doi.org/10.3389/fonc.2022.854096 |
Ejemplares similares
-
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus
Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular
Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
por: Wang, Jinfeng, et al.
Publicado: (2023) -
Molecular typing and mutational characterization of rectal neuroendocrine neoplasms
por: Duan, Xiaoling, et al.
Publicado: (2023) -
Matrine prevents the early development of hepatocellular carcinoma like lesions in rat liver
por: Shi, Jianfei, et al.
Publicado: (2019) -
Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A
por: Mi, Lili, et al.
Publicado: (2020) -
Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only
por: Wang, Jinfeng, et al.
Publicado: (2018)